Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

NCT01529840 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Genetic Disorder
Noonan Syndrome

Interventions

DRUG: somatropin
DRUG: somatropin

Sponsor

Novo Nordisk A/S